ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $129,000 | +4.9% | 1,350 | -1.5% | 0.01% | 0.0% |
| Q1 2020 | $123,000 | +68.5% | 1,370 | 0.0% | 0.01% | +133.3% |
| Q4 2019 | $73,000 | +35.2% | 1,370 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $54,000 | +54.3% | 1,370 | +63.1% | 0.00% | +100.0% |
| Q2 2019 | $35,000 | -10.3% | 840 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $39,000 | -74.7% | 840 | -76.3% | 0.00% | -80.0% |
| Q4 2018 | $154,000 | -23.8% | 3,540 | -40.4% | 0.01% | -16.7% |
| Q2 2016 | $202,000 | -77.0% | 5,940 | -74.3% | 0.01% | -79.3% |
| Q1 2015 | $879,000 | -9.4% | 23,090 | -7.2% | 0.03% | -14.7% |
| Q4 2014 | $970,000 | +17.1% | 24,890 | -9.2% | 0.03% | +9.7% |
| Q3 2014 | $828,000 | – | 27,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |